1921
Volume 103, Issue 3
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.20-0766
2020-07-24
2020-09-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/103/3/tpmd200766.html?itemId=/content/journals/10.4269/ajtmh.20-0766&mimeType=html&fmt=ahah

References

  1. Luo P, Qiu L, Liu Y, Liu XL, Zheng JL, Xue HY, Liu WH, Liu D, Li J, 2020. Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am J Trop Med Hyg 103: 6972.
    [Google Scholar]
  2. Garcia EY, 1950. Flumamine: a new synthetic analgesic and anti-flu drug. J Philipp Med Assoc 26: 287293.
    [Google Scholar]
  3. Bouchoucha M, Uzzan B, Cohen R, 2011. Metformin and digestive disorders. Diabetes Metabo 37: 9096.
    [Google Scholar]
  4. Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N, 2017. Metformin-associated lactic acidosis (MALA): moving towards a new paradigm. Diabetes Obes Metab 19: 15021512.
    [Google Scholar]
  5. Jones GC, Macklin JP, Alexander WD, 2003. Contraindications to the use of metformin. BMJ 326: 45.
    [Google Scholar]
  6. Li H et al., 2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID‐19. Diabetes Obes Metab (Epub ahead of print). Available at: https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/dom.
    [Google Scholar]
  7. Cariou B et al., 2020. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia 63: 15001515.
    [Google Scholar]
  8. Williamson EJ et al., 2020. OpenSAFELY: factors associated with COVID-19 death in 17 million patients. Nature. Available at: https://doi.org/10.1038/s41586-020-2521-4.
  9. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, Labreuche J, Mathieu D, Pattou F, Jourdain M; LICORN and the Lille COVID‐19 and Obesity Study Group, 2020. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity 28: 11951199.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.20-0766
Loading
  • Published online : 24 Jul 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error